Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children

British Journal of Haematology

Volumn 140, Issue 2, 2008, Pages 191-196

  Taj, Mary M ^a   Messahel, Boo ^a   Mycroft, Julie ^a   Pritchard Jones, Kathy ^a   Baker, Alistair ^b   Height, Susan ^b   Hadzic, Nedim ^d   Pinkerton, C Ross ^c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MATER HOSPITAL   (Australia)

^d NONE

Author keywords

Childhood; High dose methotrexate; Post transplant lymphoproliferative disease

Indexed keywords

ACICLOVIR; ASPARAGINASE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; RITUXIMAB; TACROLIMUS; VINCRISTINE;

ARTICLE; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM LYMPHOPROLIFERATIVE DISEASE; CHILD; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TOLERABILITY; HEPATOBLASTOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; RELAPSE; T CELL LYMPHOMA; TREATMENT RESPONSE;

ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; POSTOPERATIVE COMPLICATIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 37249052350     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06896.x     Document Type: Article

References (28)

1. Fohrer, C., Caillard, S., Koumarianou, A., Ellero, B., Woehl-Jaegle, M.L., Meyer, C., Epailly, E., Chenard, M.P., Lioure, B., Natarajan-Ame, S., Maloisel, F., Lutun, P., Kessler, R., Moulin, B., Bergerat, J.P., Wolf, P. Herbrecht, R. (2006) Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen. British Journal of Haematology, 134, 602 612.
2. Green, M., Michaels, M.G., Webber, S.A., Rowe, D. Reyes, J. (1999) The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatric Transplantation, 3, 271 281.
3. Gross, T.G., Bucuvalas, J.C., Park, J.R., Greiner, T.C., Hinrich, S.H., Kaufman, S.S., Langnas, A.N., McDonald, R.A., Ryckman, F.C., Shaw, B.W., Sudan, D.L. Lynch, J.C. (2005) Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. Journal of Clinical Oncology, 23, 6481 6488.
4. Haldas, J., Wang, W. Lazarchick, J. (2002) Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant. Leukemia & Lymphoma, 43, 447 450.
5. Harris, N.L., Ferry, J.A. Swerdlow, S.H. (1997) Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Seminars in Diagnostic Pathology, 14, 8 14.
6. Hayashi, R.J., Kraus, M.D., Patel, A.L., Canter, C., Cohen, A.H., Hmiel, P., Howard, T., Huddleston, C., Lowell, J.A., Mallory, Jr., G., Mendeloff, E., Molleston, J., Sweet, S. DeBaun, M.R. (2001) Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior. Journal of Pediatric Hematology/Oncology, 23, 14 18.
7. McDonald, G.B., Slattery, J.T., Bouvier, M.E., Ren, S., Batchelder, A.L., Kalhorn, T.F., Schoch, H.G., Anasetti, C. Gooley, T. (2003) Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood, 101, 2043 2048.
8. Messahel, B., Taj, M.M., Hobson, R., Hadzic, N., Ramsay, A., Hann, I. Pinkerton, R. (2006) Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review. Leukemia & Lymphoma, 47, 2584 2589.
9. Micallef, I.N., Kirk, A., Norton, A., Foran, J.M., Rohatiner, A.Z. Lister, T.A. (1999) Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma. Blood, 93, 2427 2428.
10. Nozzoli, C., Bartolozzi, B., Guidi, S., Orsi, A., Vannucchi, A.M., Leoni, F. Bosi, A. (2006) Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leukemia & Lymphoma, 47, 167 169.
11. Opelz, G. Henderson, R. (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet, 342, 1514 1516.
12. van Outryve, S., Schrijvers, D., van den, B.J., Wilmes, P., Bogers, J., van Marck, E. Vermorken, J.B. (2002) Methotrexate-associated liver toxicity in a patient with breast cancer: case report and literature review. The Netherlands Journal of Medicine, 60, 216 222.
13. Pasquale, M.A., Weppler, D., Smith, J., Icardi, M., Amador, A., Gonzalez, M., Kato, T., Tzakis, A. Ruiz, P. (2002) Burkitt s lymphoma variant of post-transplant lymphoproliferative disease (PTLD). Pathology Oncology Research, 8, 105 108.
14. Penn, I. (1991) The changing pattern of posttransplant malignancies. Transplantation Proceedings, 23, 1101 1103.
15. Penn, I. Porat, G. (1995) Central nervous system lymphomas in organ allograft recipients. Transplantation, 59, 240 244.
16. Pinkerton, C.R., Hann, I., Weston, C.L., Mapp, T., Wotherspoon, A., Hobson, R., Kelly, D.A., Vergani, D., Hadzic, D., Rees, L., Burke, M. Alero, T.J. (2002) Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry. British Journal of Haematology, 118, 456 461.
17. Rajakariar, R., Bhattacharyya, M., Norton, A., Sheaff, M., Cavenagh, J., Raftery, M.J. Yaqoob, M.M. (2004) Post transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature. American Journal of Transplantation, 4, 1534 1538.
18. Reiter, A., Schrappe, M., Ludwig, W.D., Tiemann, M., Parwaresch, R., Zimmermann, M., Schirg, E., Henze, G., Schellong, G., Gadner, H. Riehm, H. (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood, 95, 416 421.
19. Soon, C. Ilchyshyn, A. (2005) Methotrexate toxicity induced by acute renal failure. Journal of the Royal Society of Medicine, 98, 83 84.
20. Stephan, J.L., Le Deist, F., Blanche, S., Le Bidois, J., Peuchmaur, M., Lellouch-Tubiana, A., Hirn, M., Griscelli, C. Fischer, A. (1992) Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody. Transplantation, 54, 246 249.
21. Strang, A. Pullar, T. (2004) Methotrexate toxicity induced by acute renal failure. Journal of the Royal Society of Medicine, 97, 536 537.
22. Suryanarayan, K., Natkunam, Y., Berry, G., Bangs, C.D., Cherry, A. Dahl, G. (2001) Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation. Journal of Pediatric Hematology/Oncology, 23, 452 455.
23. Swerdlow, S.H. (1997) Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Seminars in Diagnostic Pathology, 14, 2 7.
24. Taylor, A.L., Marcus, R. Bradley, J.A. (2005) Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Critical Reviews in Oncology/Hematology, 56, 155 167.
25. Tetreault, S., Abler, S.L., Robbins, B. Saven, A. (1998) Peripheral T-cell lymphoma after anti-CD20 antibody therapy. Journal of Clinical Oncology, 16, 1635 1637.
26. Tsai, D.E., Hardy, C.L., Tomaszewski, J.E., Kotloff, R.M., Oltoff, K.M., Somer, B.G., Schuster, S.J., Porter, D.L., Montone, K.T. Stadtmauer, E.A. (2001) Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation, 71, 1076 1088.
27. Widemann, B.C. Adamson, P.C. (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist, 11, 694 703.
28. Zompi, S., Tulliez, M., Conti, F., Leblond, V., Gaulard, P., Blanche, P., Durand, F., Ghandi, D., Dreyfus, F., Louvel, A., Calmus, Y. Bouscary, D. (2000) Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases. Journal of Hepatology, 32, 521 527.